Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence – The ANRS CUPILT study-Reference-Cited by-同舟云学术

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence – The ANRS CUPILT study

Published:2016-10 Issue:4 Volume:65 Page:711-718
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Coilly Audrey,Fougerou-Leurent Claire,de Ledinghen Victor,Houssel-Debry Pauline,Duvoux Christophe,Di Martino Vincent,Radenne Sylvie,Kamar Nassim,D’Alteroche Louis,Leroy Vincent,Canva Valérie,Lebray Pascal,Moreno Christophe,Dumortier Jérôme,Silvain Christine,Besch Camille,Perre Philippe,Botta-Fridlund Danielle,Anty Rodolphe,Francoz Claire,Abergel Armando,Debette-Gratien Maryline,Conti Filomena,Habersetzer François,Rohel Alexandra,Rossignol Emilie,Danjou Hélène,Roque-Afonso Anne-Marie,Samuel Didier,Duclos-Vallée Jean-Charles,Pageaux Georges-Philippe

Publisher

Elsevier BV

Subject

Hepatology

Reference26 articles.

1. Epidemiology and natural history of HCV infection;Hajarizadeh;Nat Rev Gastroenterol Hepatol,2013

2. http://www.agence-biomedecine.fr/annexes/bilan2013/donnees/organes/05-foie/synthese.htm.

3. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation;Berenguer;Hepatology,2000

4. The association between hepatitis C infection and survival after orthotopic liver transplantation;Forman;Gastroenterology,2002

5. Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience;Coilly;J Hepatol,2014

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of direct antiviral agents for hepatitis C virus -induced liver diseases on registration, waiting list and liver transplant activity in France;Clinics and Research in Hepatology and Gastroenterology;2023-10

2. HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation;Clinics and Research in Hepatology and Gastroenterology;2022-11

3. Effectiveness of Direct-acting Agents After Liver Transplantation A Real-life Study in Rio de Janeiro;Archives of Medical Research;2022-09

4. A real-life study on the impact of direct-acting antivirals in the treatment of chronic hepatitis C in liver transplant recipients at two university centers in Northeastern Brazil;Revista do Instituto de Medicina Tropical de São Paulo;2021

5. Emerging Management of Hepatitis C in Transplant;Emerging Transplant Infections;2021